A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
A next generation human liver organoid system mimics how drugs provoke immune driven liver injury in susceptible individuals, ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...
News-Medical.Net on MSN
Microarray platform could help predict immune‐mediated drug‐induced liver injury
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows how a simple blood analysis can ...
Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...
Hyper-progression recurrence (HPR) after surgery for hepatocellular carcinoma (HCC) is a particularly aggressive relapse ...
A Swedish team created a test that predicts severe liver disease years ahead. It could help doctors detect risk early using routine blood data. A recent study from Karolinska Institutet, published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback